215 related articles for article (PubMed ID: 22514339)
41. Domain structure and three-dimensional model of a group II intron-encoded reverse transcriptase.
Blocker FJ; Mohr G; Conlan LH; Qi L; Belfort M; Lambowitz AM
RNA; 2005 Jan; 11(1):14-28. PubMed ID: 15574519
[TBL] [Abstract][Full Text] [Related]
42. Few basepairing-independent motifs in the apical half of the avian HBV ε RNA stem-loop determine site-specific initiation of protein-priming.
Gajer M; Dörnbrack K; Rösler C; Schmid B; Beck J; Nassal M
Sci Rep; 2017 Aug; 7(1):7120. PubMed ID: 28769080
[TBL] [Abstract][Full Text] [Related]
43. The interface between hepatitis B virus capsid proteins affects self-assembly, pregenomic RNA packaging, and reverse transcription.
Tan Z; Pionek K; Unchwaniwala N; Maguire ML; Loeb DD; Zlotnick A
J Virol; 2015 Mar; 89(6):3275-84. PubMed ID: 25568211
[TBL] [Abstract][Full Text] [Related]
44. Carbonyl J acid derivatives block protein priming of hepadnaviral P protein and DNA-dependent DNA synthesis activity of hepadnaviral nucleocapsids.
Wang YX; Wen YM; Nassal M
J Virol; 2012 Sep; 86(18):10079-92. PubMed ID: 22787212
[TBL] [Abstract][Full Text] [Related]
45. Effects of zidovudine-selected human immunodeficiency virus type 1 reverse transcriptase amino acid substitutions on processive DNA synthesis and viral replication.
Caliendo AM; Savara A; An D; DeVore K; Kaplan JC; D'Aquila RT
J Virol; 1996 Apr; 70(4):2146-53. PubMed ID: 8642636
[TBL] [Abstract][Full Text] [Related]
46. A putative new domain target for anti-hepatitis B virus: residues flanking hepatitis B virus reverse transcriptase residue 306 (rtP306).
Wang YX; Xu X; Luo C; Ma ZM; Jiang HL; Ding JP; Wen YM
J Med Virol; 2007 Jun; 79(6):676-82. PubMed ID: 17457904
[TBL] [Abstract][Full Text] [Related]
47. An interdomain RNA binding site on the hepadnaviral polymerase that is essential for reverse transcription.
Badtke MP; Khan I; Cao F; Hu J; Tavis JE
Virology; 2009 Jul; 390(1):130-8. PubMed ID: 19467554
[TBL] [Abstract][Full Text] [Related]
48. Susceptibility of feline immunodeficiency virus/human immunodeficiency virus type 1 reverse transcriptase chimeras to non-nucleoside RT inhibitors.
Auwerx J; Esnouf R; De Clercq E; Balzarini J
Mol Pharmacol; 2004 Jan; 65(1):244-51. PubMed ID: 14722257
[TBL] [Abstract][Full Text] [Related]
49. Site-directed mutagenesis of human immunodeficiency virus type 1 reverse transcriptase at amino acid position 138.
Pelemans H; Aertsen A; Van Laethem K; Vandamme AM; De Clercq E; Pérez-Pérez MJ; San-Félix A; Velázquez S; Camarasa MJ; Balzarini J
Virology; 2001 Feb; 280(1):97-106. PubMed ID: 11162823
[TBL] [Abstract][Full Text] [Related]
50. Predicted structure of the hepatitis B virus polymerase reveals an ancient conserved protein fold.
Tajwar R; Bradley DP; Ponzar NL; Tavis JE
Protein Sci; 2022 Oct; 31(10):e4421. PubMed ID: 36173165
[TBL] [Abstract][Full Text] [Related]
51. Mechanism of inhibition of duck hepatitis B virus polymerase by (-)-beta-L-2',3'-dideoxy-3'-thiacytidine.
Severini A; Liu XY; Wilson JS; Tyrrell DL
Antimicrob Agents Chemother; 1995 Jul; 39(7):1430-5. PubMed ID: 7492080
[TBL] [Abstract][Full Text] [Related]
52. A bulged region of the hepatitis B virus RNA encapsidation signal contains the replication origin for discontinuous first-strand DNA synthesis.
Nassal M; Rieger A
J Virol; 1996 May; 70(5):2764-73. PubMed ID: 8627750
[TBL] [Abstract][Full Text] [Related]
53. Mutations affecting hepadnavirus plus-strand DNA synthesis dissociate primer cleavage from translocation and reveal the origin of linear viral DNA.
Staprans S; Loeb DD; Ganem D
J Virol; 1991 Mar; 65(3):1255-62. PubMed ID: 1704925
[TBL] [Abstract][Full Text] [Related]
54. Structure and functional implications of the polymerase active site region in a complex of HIV-1 RT with a double-stranded DNA template-primer and an antibody Fab fragment at 2.8 A resolution.
Ding J; Das K; Hsiou Y; Sarafianos SG; Clark AD; Jacobo-Molina A; Tantillo C; Hughes SH; Arnold E
J Mol Biol; 1998 Dec; 284(4):1095-111. PubMed ID: 9837729
[TBL] [Abstract][Full Text] [Related]
55. Interaction of the Ty3 reverse transcriptase thumb subdomain with template-primer.
Bibillo A; Lener D; Tewari A; Le Grice SF
J Biol Chem; 2005 Aug; 280(34):30282-90. PubMed ID: 15944162
[TBL] [Abstract][Full Text] [Related]
56. A sensitive procedure for mapping the boundaries of RNA elements binding in vitro translated proteins defines a minimal hepatitis B virus encapsidation signal.
Beck J; Nassal M
Nucleic Acids Res; 1996 Nov; 24(21):4364-6. PubMed ID: 8932398
[TBL] [Abstract][Full Text] [Related]
57. Distinct requirement for two stages of protein-primed initiation of reverse transcription in hepadnaviruses.
Wang X; Hu J
J Virol; 2002 Jun; 76(12):5857-65. PubMed ID: 12021318
[TBL] [Abstract][Full Text] [Related]
58. Evidence for activation of the hepatitis B virus polymerase by binding of its RNA template.
Tavis JE; Ganem D
J Virol; 1996 Sep; 70(9):5741-50. PubMed ID: 8709189
[TBL] [Abstract][Full Text] [Related]
59. Regulation of multiple stages of hepadnavirus replication by the carboxyl-terminal domain of viral core protein in trans.
Liu K; Ludgate L; Yuan Z; Hu J
J Virol; 2015 Mar; 89(5):2918-30. PubMed ID: 25540387
[TBL] [Abstract][Full Text] [Related]
60. Sequences in the terminal protein and reverse transcriptase domains of the hepatitis B virus polymerase contribute to RNA binding and encapsidation.
Cao F; Jones S; Li W; Cheng X; Hu Y; Hu J; Tavis JE
J Viral Hepat; 2014 Dec; 21(12):882-93. PubMed ID: 24401091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
